Phase I Trial to Evaluate the Potential Influence of Pantoprazole on the Pharmacokinetics of Pritelivir
Condition:   HSV Infection Interventions:   Drug: Pritelivir;   Drug: ESO and pritelivir Sponsor:   AiCuris Anti-infective Cures AG Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2022 Category: Research Source Type: clinical trials

Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial
This study aims to compare the efficacy and safety of 12 months and 1 month of pantoprazole treatment in preventing DAPT-related upper gastrointestinal mucosal injury after CABG.Trial registrationClinicalTrials.gov NCT03908593. (Source: Trials)
Source: Trials - July 15, 2022 Category: Research Source Type: clinical trials

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Conditions:   Pancreatic Cancer;   Pancreas Cancer;   Ampullary Cancer;   Pancreas Neuroendocrine Tumor;   Pancreatitis;   Distal Extrahepatic Cholangiocarcinoma;   Duodenal Cancer Interventions:   Drug: Placebo;   Drug: Pantoprazole Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2022 Category: Research Source Type: clinical trials